For instance, cyclosporin A (CsA), a well-characterized calcineurin inhibitor, prevents FLNA dephosphorylation [18], which may, in turn, promote HCC progression by activating MRTF-A/SRF transcription. The gene discussed is FLNA; the disease is hepatocellular carcinoma.